These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 29745914)

  • 1. WEIGHT LOSS IN A YOUNG PATIENT WITH TYPE 2 DIABETES: CHALLENGES OF DIABETES MANAGEMENT USING ONLINE PROGRAM OF GOOD NUTRITION (CASE REPORT).
    Krylov V
    Georgian Med News; 2018 Apr; (277):48-52. PubMed ID: 29745914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Study: Weight loss in a patient with type 2 diabetes: Challenges of diabetes management.
    Lotfi K; Palmer K; Apovian CM
    Obesity (Silver Spring); 2015 Apr; 23 Suppl 1():S11-2. PubMed ID: 25900868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.
    Holland-Carter L; Tuerk PW; Wadden TA; Fujioka KN; Becker LE; Miller-Kovach K; Hollander PL; Garvey WT; Weiss D; Rubino DM; Kushner RF; Malcolm RJ; Raum WJ; Hermayer KL; Veliko JL; Rost SL; Sora ND; Salyer JL; O'Neil PM
    J Diabetes Complications; 2017 May; 31(5):891-897. PubMed ID: 28319001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure-response analyses of liraglutide 3.0 mg for weight management.
    Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
    Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity in 2015: Advances in managing obesity.
    Dixon JB
    Nat Rev Endocrinol; 2016 Feb; 12(2):65-6. PubMed ID: 26729038
    [No Abstract]   [Full Text] [Related]  

  • 8. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
    Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
    J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy for obesity].
    Bruun JM
    Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Simple obesity in children. A study on the role of nutritional factors].
    Weker H
    Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention: nutrition therapy and physical activity.
    Evert AB; Riddell MC
    Med Clin North Am; 2015 Jan; 99(1):69-85. PubMed ID: 25456644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction.
    Pastel E; McCulloch LJ; Ward R; Joshi S; Gooding KM; Shore AC; Kos K
    Clin Sci (Lond); 2017 Mar; 131(5):343-353. PubMed ID: 28049736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases.
    Noya G; Cossu ML; Coppola M; Tonolo G; Angius MF; Fais E; Ruggiu M
    Obes Surg; 1998 Feb; 8(1):67-72. PubMed ID: 9562490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity treatment with liraglutide in a patient with Prader-Willi syndrome: a case report].
    Cadena-Obando DA; Molina-Ayala MA; Ferreira-Hermosillo A
    Nutr Hosp; 2018 May; 35(3):743-746. PubMed ID: 29974787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Diabetes.
    Aberle J; Lautenbach A; Meyhöfer S; Schmid SM; Selig L; Blüher M
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(S 01):S44-S51. PubMed ID: 33352596
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of a Shared Medical Appointment Lifestyle Intervention on Weight and Lipid Parameters in Individuals with Type 2 Diabetes: A Clinical Pilot.
    Guthrie GE; Bogue RJ
    J Am Coll Nutr; 2015; 34(4):300-9. PubMed ID: 25757855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Challenges in the treatment of patients with type 2 diabetes mellitus and obesity].
    Manzanares Errazu JM
    Nutr Hosp; 2002 Feb; 17 Suppl 1():1-6. PubMed ID: 11928531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss.
    Vetter ML; Amaro A; Volger S
    Postgrad Med; 2014 Jan; 126(1):139-52. PubMed ID: 24393761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.